NFL Biosciences S.A. carries a market capitalization of 12.42M, placing it among publicly traded companies globally.
| Market Cap | 12.42M |
| Enterprise Value | N/A |
NFL Biosciences S.A.'s stock has declined approximately -18.33333% over the past 52 weeks. The 50-day moving average sits at 1.01, while the 200-day moving average is 1.14.
| Beta (5Y) | N/A |
| 52-Week Price Change | -18.33333% |
| 50-Day Moving Average | 1.01 |
| 200-Day Moving Average | 1.14 |
| Average Volume (20 Days) | N/A |